{"product_id":"university-of-miami-thinking-through-alzheimer-s-exploring-cognition-psychopharmacology-and-geriatric-psychiatry-2026","title":"University of Miami Thinking Through Alzheimer’s: Exploring Cognition, Psychopharmacology and Geriatric Psychiatry 2026","description":"\u003cdiv class=\"prod-edition\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"woocommerce-tabs wc-tabs-wrapper\"\u003e\r\n\u003cdiv id=\"tab-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content wc-tab\" role=\"tabpanel\" aria-labelledby=\"tab-title-description\"\u003e\r\n\u003ch3\u003eUniversity of Miami Thinking Through Alzheimer’s: Exploring Cognition, Psychopharmacology and Geriatric Psychiatry 2026\u003c\/h3\u003e\r\n\u003cdiv class=\"activitysectionbold\"\u003eONly Videos no PDFs\u003c\/div\u003e\r\n\u003cdiv\u003eFeb 23 – 27, 2026\u003c\/div\u003e\r\n\u003cdiv\u003e\r\n\u003ch3 class=\"detail-title\"\u003eOVERVIEW\u003c\/h3\u003e\r\n\u003cdiv class=\"details-desc\"\u003e\r\n\u003cdiv\u003e\r\n\r\nThinking Through Alzheimer’s: Exploring Cognition, Psychopharmacology and Geriatric Psychiatry is organized by University of Miami Miller School of Medicine Division of Continuing Medical Education and will be held from Feb 23 – 27, 2026 at The Sunny Miami Sunny Isles Beach, Curio Collection by Hilton, Sunny Isles Beach, Florida, United States of America.\r\n\r\n\u003cstrong\u003eDescription:\u003c\/strong\u003e\r\nBrain health is recognized as an essential part of successful aging. To promote longevity and quality of life, optimal brain functioning across cognitive, social, emotional, and behavioral domains allows a person to realize their full potential over their lifetime.\r\n\r\nAnxiety, depression and other mental health condition in later life can reduce longevity, increase the risk of medical and cognitive disorders and lead to poorer outcomes. Most concerning is the fact that the prevalence of cognitive disorders is increasing rapidly as people live longer. Reducing the risk of cognitive disorders such as Alzheimer’s Disease and Related Dementias (ADRD) is as essential to the clinician as reducing hypertension and diabetes in reducing cardiovascular disease.\r\n\r\nThis seminar is designed to educate the practitioners and equip them with essential knowledge and state-of-the-art scientific methods to diagnose Alzheimer’s Disease and Related Dementias (ADRD) at its earliest stages and assist patients and their loved ones. Understanding normal cognitive neurology and stradegies to reduce the risk of developing Alzheimer’s disease will also be discussed. Drawing on the presenters’ vast scientific and clinical expertise, the participants will be able to differentiate different cognitive syndromes and the etiological underpinnings of various clinical presentations. In addition, the participant will be familiarized with state-of-the-art neuropsychological and novel neuroimaging and plasma-based biomarkers methods to detect the earliest stages of Alzheimer’s Disease.\r\n\r\nThis presentation will also provide a comprehensive review of essential geriatric psychopharmacology in the treatment of the most common psychiatric and mental health conditions as well as the latest in emerging pharmacological agents in the treatment and management of Alzheimer’s Disease and its comorbid psychiatric and behavioral manifestations.\r\n\r\n\u003cstrong\u003eObjectives:\u003c\/strong\u003e\r\nUpon completion of this activity, participants will be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003eDescribe the promotion of brain health and longevity through evidence-based prevention.\u003c\/li\u003e\r\n \t\u003cli\u003eDifferentiate between normal cognitive neurology, mild cognitive impairment (MCI), and clinical dementia.\u003c\/li\u003e\r\n \t\u003cli\u003eDemonstrate how to identify the underlying brain disorders causing clinical cognitive impairment in older adults.\u003c\/li\u003e\r\n \t\u003cli\u003eIdentify the evidence-based, emerging brain biomarkers in cognitive disorders that help to diagnose at-risk older individuals for Alzheimer’s Disease and Related Dementias (ADRD).\u003c\/li\u003e\r\n \t\u003cli\u003eIdentify the role of traditional and novel cognitive neuropsychological testing in early diagnosis of cognitive disorders in older individuals.\u003c\/li\u003e\r\n \t\u003cli\u003eDifferentiate Alzheimer’s Disease from non- Alzheimer’s Disease pathology\u003c\/li\u003e\r\n \t\u003cli\u003eDescribe current pharmacological and nonpharmacological approaches to the treatment of Alzheimer’s Disease and Related Dementias (ADRD).\u003c\/li\u003e\r\n \t\u003cli\u003eIdentify the emerging and promising agents in the treatment and management of early Alzheimer’s disease (AD).\u003c\/li\u003e\r\n \t\u003cli\u003eRecognize geriatric psychopharmacology and how to optimally treat the more challenging geriatric mental health conditions.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003cdiv\u003e\r\n\u003ch3 class=\"detail-title\"\u003eSPECIALITIES\u003c\/h3\u003e\r\n\u003cspan class=\"specialities-item align-items-center\"\u003eNeurologyPharmacologyGeriatricsPsychiatry\u003c\/span\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003cdiv\u003etitles\u003c\/div\u003e\r\n\u003cdiv\u003e\r\n\u003ch2 data-section-id=\"6wezuq\" data-start=\"92\" data-end=\"148\"\u003e\u003cspan role=\"text\"\u003e\u003cstrong data-start=\"98\" data-end=\"148\"\u003ethinking Through Alzheimer’s 2026 – Video List\u003c\/strong\u003e\u003c\/span\u003e\u003c\/h2\u003e\r\n\u003cdiv class=\"TyagGW_tableContainer\"\u003e\r\n\u003cdiv class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\"\u003e\r\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-start=\"150\" data-end=\"1104\"\u003e\r\n\u003cthead data-start=\"150\" data-end=\"177\"\u003e\r\n\u003ctr data-start=\"150\" data-end=\"177\"\u003e\r\n\u003cth class=\"\" data-start=\"150\" data-end=\"158\" data-col-size=\"sm\"\u003eSR No\u003c\/th\u003e\r\n\u003cth class=\"\" data-start=\"158\" data-end=\"166\" data-col-size=\"md\"\u003eTitle\u003c\/th\u003e\r\n\u003cth class=\"\" data-start=\"166\" data-end=\"177\" data-col-size=\"sm\"\u003eRuntime\u003c\/th\u003e\r\n\u003c\/tr\u003e\r\n\u003c\/thead\u003e\r\n\u003ctbody data-start=\"204\" data-end=\"1104\"\u003e\r\n\u003ctr data-start=\"204\" data-end=\"272\"\u003e\r\n\u003ctd data-start=\"204\" data-end=\"208\" data-col-size=\"sm\"\u003e1\u003c\/td\u003e\r\n\u003ctd data-start=\"208\" data-end=\"263\" data-col-size=\"md\"\u003eAlzheimer’s and Pre-Alzheimer’s: Emerging Biomarkers\u003c\/td\u003e\r\n\u003ctd data-start=\"263\" data-end=\"272\" data-col-size=\"sm\"\u003e65:52\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr data-start=\"273\" data-end=\"340\"\u003e\r\n\u003ctd data-start=\"273\" data-end=\"277\" data-col-size=\"sm\"\u003e2\u003c\/td\u003e\r\n\u003ctd data-start=\"277\" data-end=\"331\" data-col-size=\"md\"\u003eAdvances in Cognitive Neuropsychological Assessment\u003c\/td\u003e\r\n\u003ctd data-col-size=\"sm\" data-start=\"331\" data-end=\"340\"\u003e35:52\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr data-start=\"341\" data-end=\"455\"\u003e\r\n\u003ctd data-start=\"341\" data-end=\"345\" data-col-size=\"sm\"\u003e3\u003c\/td\u003e\r\n\u003ctd data-start=\"345\" data-end=\"446\" data-col-size=\"md\"\u003eAlzheimer Disease and Related Dementias: Integrating Pharmacologic and Nonpharmacologic Management\u003c\/td\u003e\r\n\u003ctd data-col-size=\"sm\" data-start=\"446\" data-end=\"455\"\u003e48:04\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr data-start=\"456\" data-end=\"564\"\u003e\r\n\u003ctd data-start=\"456\" data-end=\"460\" data-col-size=\"sm\"\u003e4\u003c\/td\u003e\r\n\u003ctd data-start=\"460\" data-end=\"555\" data-col-size=\"md\"\u003eAlzheimer Disease Management: The Newest Therapeutic Strategies and Treatment Considerations\u003c\/td\u003e\r\n\u003ctd data-col-size=\"sm\" data-start=\"555\" data-end=\"564\"\u003e48:46\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr data-start=\"565\" data-end=\"641\"\u003e\r\n\u003ctd data-start=\"565\" data-end=\"569\" data-col-size=\"sm\"\u003e5\u003c\/td\u003e\r\n\u003ctd data-start=\"569\" data-end=\"632\" data-col-size=\"md\"\u003eDementia Care: Managing Caregiver Burden and Family Dynamics\u003c\/td\u003e\r\n\u003ctd data-col-size=\"sm\" data-start=\"632\" data-end=\"641\"\u003e49:42\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr data-start=\"642\" data-end=\"740\"\u003e\r\n\u003ctd data-start=\"642\" data-end=\"646\" data-col-size=\"sm\"\u003e6\u003c\/td\u003e\r\n\u003ctd data-start=\"646\" data-end=\"731\" data-col-size=\"md\"\u003ePsychopharmacology in Older Adults: Managing Drug Interactions and Adverse Effects\u003c\/td\u003e\r\n\u003ctd data-col-size=\"sm\" data-start=\"731\" data-end=\"740\"\u003e48:17\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr data-start=\"741\" data-end=\"842\"\u003e\r\n\u003ctd data-start=\"741\" data-end=\"745\" data-col-size=\"sm\"\u003e7\u003c\/td\u003e\r\n\u003ctd data-col-size=\"md\" data-start=\"745\" data-end=\"833\"\u003eAmnestic Mild Cognitive Impairment: Identifying Patients at High Risk for Progression\u003c\/td\u003e\r\n\u003ctd data-col-size=\"sm\" data-start=\"833\" data-end=\"842\"\u003e47:20\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr data-start=\"843\" data-end=\"926\"\u003e\r\n\u003ctd data-start=\"843\" data-end=\"847\" data-col-size=\"sm\"\u003e8\u003c\/td\u003e\r\n\u003ctd data-start=\"847\" data-end=\"917\" data-col-size=\"md\"\u003eDementia Subtypes: Key Diagnostic Distinctions in Clinical Practice\u003c\/td\u003e\r\n\u003ctd data-col-size=\"sm\" data-start=\"917\" data-end=\"926\"\u003e43:29\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr data-start=\"927\" data-end=\"1014\"\u003e\r\n\u003ctd data-start=\"927\" data-end=\"931\" data-col-size=\"sm\"\u003e9\u003c\/td\u003e\r\n\u003ctd data-start=\"931\" data-end=\"1005\" data-col-size=\"md\"\u003eAlzheimer Disease Risk Reduction: Strategies to Delay Cognitive Decline\u003c\/td\u003e\r\n\u003ctd data-col-size=\"sm\" data-start=\"1005\" data-end=\"1014\"\u003e55:49\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr data-start=\"1015\" data-end=\"1104\"\u003e\r\n\u003ctd data-start=\"1015\" data-end=\"1020\" data-col-size=\"sm\"\u003e10\u003c\/td\u003e\r\n\u003ctd data-start=\"1020\" data-end=\"1095\" data-col-size=\"md\"\u003eNormal Aging and Cognition: Maintaining Cognitive Health in Older Adults\u003c\/td\u003e\r\n\u003ctd data-col-size=\"sm\" data-start=\"1095\" data-end=\"1104\"\u003e50:30\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003c\/tbody\u003e\r\n\u003c\/table\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"Amboss","offers":[{"title":"Default Title","offer_id":42954708320354,"sku":"MED-AMB08580","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/University-of-Miami-Thinking-Through-Alzheimers.png?v=1779382866","url":"https:\/\/meducourse.com\/products\/university-of-miami-thinking-through-alzheimer-s-exploring-cognition-psychopharmacology-and-geriatric-psychiatry-2026","provider":"Meducourse","version":"1.0","type":"link"}